Wearable device to track perimenopausal and menopausal symptoms
Official title: An Observational Virtual Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women
Run by IdentifyHer Limited · NCT07022925 · Data updated 2026-11-12
This project will test whether a wearable sensor can accurately detect hot flashes, night sweats, sleep problems, and anxiety-related signals in women aged 35–55 going through perimenopause by comparing device readings with daily reports in an app.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 35 Years to 55 Years |
| Sex | Women only |
| Enrollment | 110 (estimated) |
| Sponsor | IdentifyHer Limited Industry-sponsored |
| Locations | 1 site (London, Ontario) |
| Status | Recruiting |
| Started | July 4, 2025 |
| Main results expected | October 2025 |
| Study ends | October 2025 |
| Registry record updated | September 18, 2025 |
| Trial ID | NCT07022925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 35–55 who self-identify as perimenopausal, experience hot flushes or night sweats, are generally healthy, agree to use contraception if of child-bearing potential, and can comply with wearing the device and completing daily app entries are ideal candidates.
✕Probably not a fit
Women who are not experiencing vasomotor symptoms, are clearly postmenopausal, are pregnant or planning pregnancy, have allergies or sensitivities to wearable materials, or have unstable medical conditions are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study asks perimenopausal women to wear IdentifyHer’s non-invasive wearable sensor and complete a daily electronic diary plus questionnaires on stress, anxiety, and sleep. The device’s algorithm-generated events will be compared to participant self-reports in the app to measure agreement and accuracy. Outcomes will include metrics such as sensitivity, specificity, and overall concordance for vasomotor symptoms, sleep disturbances, and anxiety-related patterns. The study is run with KGK Science Inc. in London, Ontario and enrolls generally healthy women who report hot flashes or night sweats.
Why it matters
Potential benefit: If successful, the wearable could provide objective, continuous symptom tracking to help women and clinicians monitor perimenopausal symptoms and treatment effects.
How similar studies have gone: Previous research using physiological wearables to detect vasomotor events and sleep disturbances has shown promising but variable results, and rigorous validation against daily self-report remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Females between 35-55 years of age, inclusive 2. Self-reported perimenopausal women experiencing hot flushes or night sweats 3. Individuals of child-bearing potential must confirm they are not pregnant, do not plan to become pregnant, and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include: * Double-barrier method * Intrauterine devices * Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s) * Vasectomy of partner at least 6 months prior to screening * Abstinence 4. Agrees to maintain current lifestyle as much as possible throughout the study, including diet, exercise, supplements/medications, and sleep 5. Provided voluntary and informed consent to participate in the study 6. Generally healthy as determined by medical history with no unstable diagnosed medical conditions Exclusion Criteria: 1. Allergy or sensitivity to adhesive used for wearing the investigational device 2. Self-reported use of a pacemaker 3. Self-reported unstable diagnosed anxiety disorder 4. Self-reported sleep disorder requiring medical treatment 5. Self-reported skin conditions or sensitive skin around the area of application 6. Self-reported surgery in the past three months or individuals who have planned surgery during the course of the study 7. Alcohol intake average of ˃1 standard drink per day 8. Alcohol or drug abuse within the last 12 months that has required treatment 9. Current use of prescribed and/or over-the-counter (OTC) medications/supplements that may impact data recorded by the investigational device (see Section 7.3) 10. Participation in other clinical research studies 30 days prior to screening 11. Individuals who are unable to give informed consent 12. Any other condition or lifestyle factor, that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant
Where it's running
-
KGK Science Inc.
London, Ontario, Canada Recruiting
Study contacts
- Principal investigator: David Crowley, MD — KGK Science Inc.
- Study coordinator: Marc Moulin, PhD
- Email: mmoulin@kgkscience.com
- Phone: +12267819094;ext=300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotic Intake to See If It Helps Perimenopausal Women Think and Feel Better
We’re testing whether a multi-strain probiotic can improve emotional processing and cognitive function in perimenopausal women who have mood or cognitive concerns.
-
Understanding immune clues to depression in perimenopause
This study tests whether immune and epigenetic changes during perimenopause help explain why some women develop depression.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Plant extract supplement for menopausal symptoms in women around menopause
A plant-extract dietary supplement is being tested to see if it helps hot flashes and related symptoms in women aged 42–60 who are nearing or just past menopause, compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.